Special Issue "Recent Advances in Pancreatic Ductal Adenocarcinoma"
Deadline for manuscript submissions: 30 June 2021.
Interests: pancreatic ductal adenocarcinoma; biomarkers; tumour microenvironment
Interests: pancreatic ductal adenocarcinoma, surgery, post-surgical complications, prognostic biomarkers
Interests: pancreatic ductal adenocarcinoma, surgery, neoadjuvant chemotherapy
We would like to invite you to submit either original research or review articles for this Special Issue on “Recent Advances in Pancreatic Ductal Adenocarcinoma (PDAC)”. The journal has an impact factor of 6.1, and you are receiving this letter as a personal invitation on behalf of one of the editors.
This Special Issue will focus on the recent advances in the field of PDAC research. The topics will include but are not limited to advances in (1) pancreatic cancer surgery, especially around the equipoise of laparoscopic/robotic vs. open resections, arterial resections, and surgical management of stage 4 PDAC; (2) diagnostic and prognostic biomarkers in blood, urine, and/or tissues; (3) the pancreatic tumor microenvironment; (4) chemotherapy in neoadjuvant, adjuvant, and palliative settings; (5) radiotherapy or radio/chemotherapy; (6) postsurgical complications; (7) novel targeted therapies; (8) immunotherapy; and (9) pancreatic tumor microbiome.
Thank you for your consideration.
Dr Sumit Sahni
Dr Anubhav Mittal
Prof Dr. Jaswinder Samra
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pancreatic ductal adenocarcinoma
- distal pancreatectomy
- neoadjuvant chemotherapy
- postsurgical complications
- targeted therapies
- tumor microenvironment